Barclays PLC Syros Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.69 - $1.21 $6,449 - $11,309
-9,347 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.02 - $3.8 $61,740 - $230,014
-60,530 Reduced 86.62%
9,347 $11,000
Q4 2021

Feb 14, 2022
BUY
$3.26 - $4.66 $81,545 - $116,565
25,014 Added 55.76%
69,877 $228,000
Q3 2021

Nov 09, 2021
SELL
$4.08 - $5.66 $56,703 - $78,662
-13,898 Reduced 23.65%
44,863 $200,000
Q2 2021

Aug 13, 2021
SELL
$5.01 - $7.48 $91,597 - $136,756
-18,283 Reduced 23.73%
58,761 $320,000
Q1 2021

May 13, 2021
BUY
$7.19 - $14.95 $455,141 - $946,364
63,302 Added 460.65%
77,044 $577,000
Q4 2020

Feb 11, 2021
SELL
$6.66 - $14.66 $35,351 - $77,815
-5,308 Reduced 27.86%
13,742 $150,000
Q3 2020

Nov 12, 2020
SELL
$8.69 - $14.47 $33,256 - $55,376
-3,827 Reduced 16.73%
19,050 $168,000
Q2 2020

Aug 12, 2020
BUY
$5.21 - $11.03 $59,326 - $125,598
11,387 Added 99.1%
22,877 $244,000
Q1 2020

May 13, 2020
SELL
$4.46 - $9.2 $107,392 - $221,526
-24,079 Reduced 67.7%
11,490 $68,000
Q4 2019

Feb 10, 2020
BUY
$4.52 - $10.1 $79,913 - $178,568
17,680 Added 98.83%
35,569 $245,000
Q3 2019

Nov 14, 2019
SELL
$7.14 - $11.65 $31,830 - $51,935
-4,458 Reduced 19.95%
17,889 $185,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $81,939 - $145,255
14,898 Added 200.0%
22,347 $207,000
Q1 2019

May 15, 2019
BUY
$5.51 - $9.59 $24,894 - $43,327
4,518 Added 154.15%
7,449 $68,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $53,474 - $109,260
-9,635 Reduced 76.68%
2,931 $17,000
Q3 2018

Nov 14, 2018
BUY
$9.74 - $12.92 $104,919 - $139,174
10,772 Added 600.45%
12,566 $150,000
Q2 2018

Aug 14, 2018
SELL
$10.16 - $13.65 $14,335 - $19,260
-1,411 Reduced 44.02%
1,794 $18,000
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $11,562 - $15,848
1,221 Added 61.54%
3,205 $41,000
Q4 2017

Feb 14, 2018
BUY
$8.45 - $17.48 $13,486 - $27,898
1,596 Added 411.34%
1,984 $19,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $5,245 - $9,215
388
388 $5,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email